Fundraising FoxCarlsmed
Carlsbad, US · Founded 2018 · Delaware corporation · 8 known investors
Find your way into Carlsmed
Sign up to find every way you can get introduced to Carlsmed
- Your email: who you already know at Carlsmed, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Carlsmed team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons. The company operates in the medical device industry with FDA-cleared lumbar and cervical fusion products.
Founders & leadership
Carlsmed was founded in 2018 by Mike Cordonnier and Niall Casey.
MC
Mike CordonnierCo-Founder, President & CEO
NC
Niall CaseyCo-Founder & Chief Intellectual Property Officer
SH
Shariq HussainChief Technology Officer
AA
Alexander ArrowExecutive
SS
Sharon SchulzkiChief Clinical & Market Access Officer
LG
Leo GreensteinChief Financial Officer
JK
Jennifer KamocsayChief Legal Officer
SD
Scott DurallChief Commercial Officer
KS
Kevin SidowNamed on SEC filing
MS
Mark SingerNamed on SEC filing
Board
JR
RM
Investors · 8
Alliance of Angelslisted by Alliance of AngelsSeattle
How we know: Alliance of Angels's portfolio page · Not right? Tell us
.jpeg){kind=logo}
B Capital Grouplisted by B Capital GroupSan Francisco · $10M – $50M
How we know: B Capital Group's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Prota Ventureslisted by Prota VenturesPortland
How we know: Prota Ventures's portfolio page · Not right? Tell us
US Venture Partnerslisted by US Venture PartnersMenlo Park · $500K – $10M
How we know: US Venture Partners's portfolio page · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$109.1M disclosed across 4 rounds · 2019–2024
▶$64.5MraisedFeb 2025 · 7 investors · OtherRule 506(b)
▶$64.5MraisedFeb 2025 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert MittendorffDirector
- Kevin O'BoyleDirector
- Leonard GreensteinExecutive Officer
- Durall ScottExecutive Officer
- Niall CaseyExecutive Officer, Director
- Philip YoungDirector
- Michael CordonnierExecutive Officer, Director
- Kevin SidowDirector
- Sharon SchulzkiExecutive Officer
- Shariq HussainExecutive Officer
- Jonathan RootDirector
- Offering amount
- $64.5M
- Amount sold
- $64.5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedApr 2022 · 21 investors · BiotechnologyRule 506(b)
▶$30MraisedApr 2022 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin SidowDirector
- Shariq HussainExecutive Officer
- Alexander ArrowExecutive Officer
- Jonathan RootDirector
- Robert MittendorffDirector
- Sharon SchulzkiExecutive Officer
- Michael CordonnierExecutive Officer, Director
- Philip YoungDirector
- Mark SingerExecutive Officer
- Niall CaseyExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$12.6MraisedDec 2020 · 50 investors · BiotechnologyRule 506(b)
▶$12.6MraisedDec 2020 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander ArrowExecutive Officer
- Sharon SchulzkiExecutive Officer
- Niall CaseyExecutive Officer, Director
- Philip YoungDirector
- Kevin SidowDirector
- Shariq HussainExecutive Officer
- Justin EsterbergExecutive Officer
- Michael CordonnierExecutive Officer, Director
- Jonathon RootDirector
- Offering amount
- $12.6M
- Amount sold
- $12.6M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedMay 2020 · 40 investors · BiotechnologyRule 506(b)
▶$2MraisedMay 2020 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael CordonnierExecutive Officer, Director
- Jeffrey RohDirector
- Justin EsterbergExecutive Officer, Director
- Alexander ArrowExecutive Officer
- Sharon SchulzkiExecutive Officer
- Niall CaseyDirector
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Alphatec Spine, Inc.ATEC Spine develops surgical devices and approaches for spine surgery, targeting decompression, stabilization, and alignment for surgeons treating spinal pathologies. The company operates in the medical technology sector focused on spine surgery.
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Companies working in the same space as Carlsmed.
Frequently asked questions
- What does Carlsmed do?
- Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons. The company operates in the medical device industry with FDA-cleared lumbar and cervical fusion products.
- Who founded Carlsmed?
- Carlsmed was founded by Mike Cordonnier, Niall Casey in 2018.
- Who are Carlsmed's investors?
- Carlsmed's investors include Alliance of Angels, B Capital Group, B4 Capital, Cove Fund, Pasadena Angels, Prota Ventures, US Venture Partners, Wavemaker Three-Sixty Health.
- How much funding has Carlsmed raised?
- Carlsmed has disclosed $109.1M raised across 4 rounds.
- Where is Carlsmed headquartered?
- Carlsmed is headquartered in Carlsbad, US.